Sepsis Diagnostics Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2020 - 2025

Report Code: HCR 0530 Report Format: PDF + Excel (Delivery in 48 Hrs)
Sepsis Diagnostics Market Overview
Sepsis Diagnostics Market size is estimated to reach $801.19m by 2025, growing at a CAGR of 8.32% during the forecast period 2020-2025. Sepsis is a fatal condition caused by the body’s response to an infection. The body usually releases chemicals into the bloodstream to fight infection. Sepsis occurs when the body’s response to these chemicals is unbalanced, leading to the changes that can damage multiple organ systems. Sepsis is one of the common causes in hospitalized patients. Increasing prevalence in hospital acquired infections which must be diagnosed boosts the market growth. The rising number of surgical procedure and increase in the number of product approvals for diagnosis of sepsis are estimated to support the growth of the global sepsis diagnostics market in the forecast period 2020-2025.

Sepsis Diagnostics Market Report Coverage
The report: “Sepsis Diagnostics Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Sepsis Diagnostics Market. 
By Technology: Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers.
By Product: Blood Culture Media, Assays & Reagents, Instruments, and Software.
By Method: Conventional Diagnostics, Automated Diagnostics.
By Pathogen: Bacterial Sepsis, Fungal Sepsis, and other pathogens.
By Test Type: Laboratory tests, Point-of-Care Tests.
By End User: Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes.
By Geography: North America, Asia-Pacific, Europe, and Rest of World.

Key Takeaways
  • Geographically, North America’s Sepsis Diagnostics market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to increasing demand for better healthcare facilities.
  • Rise in cases of hospital acquired infections have helped in significant growth of Sepsis Diagnostics market.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Sepsis Diagnostics Market report.
  • Lack of adequate skilled and well trained workforce is anticipated to hamper the market growth of the Sepsis Diagnostics market.

By Product - Segment Analysis
The global Sepsis Diagnostics market based on Product has Blood Culture Media, Assays & Reagents, Instruments, and Software. The blood culture media segment registered for highest market share in 2019 and is set to continue for the forecast period (2020-2025). This segment is attributed to the fact that blood culture media is considered as the cost-effective and gold standard method by most of the clinicians.

By Test Type - Segment Analysis
Based on test type, the market is segmented into laboratory tests and Point-of-Care tests. The laboratory tests segment registers for the highest market share in 2019 and is set to continue for the forecast period (2020-2025) owing to the rising number of blood culture tests being conducted in laboratories. Growing number of diagnostic laboratories coupled with the availability of advanced instruments are anticipated to foster the growth of this segment.

By Geography - Segment Analysis
The global Sepsis Diagnostics Market by geography had the dominant share in North America with in terms of revenue in 2019. This is owing to factors such as increasing demand for better healthcare facilities, high per capita healthcare expenditure, and increasing incidences of chronic diseases such as cancer, diabetes, and others leading to increasing hospital admissions and rising incidences of hospital acquired infections, and growing adoption of new and advanced diagnostic techniques. However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR during the forecast period owing to the increasing geriatric population in the region. 

Drivers – Sepsis Diagnostics Market
  • Increased rate of hospital-acquired diseases
The demand for Sepsis Diagnostics is driving forward owing to the increasing prevalence of sepsis, the growing burden of hospital-acquired infections, the increasing number of pneumonia cases, the rise in the number of sepsis procedures, and an increase in funding for sepsis-related research activities. Besides, rise in demand for antibiotic resistant bacterial strains, aging population are acting as drivers for supporting the growth of the Sepsis Diagnostics market.

Challenges – Sepsis Diagnostics Market
  • Lack of skilled workforce 
Sepsis Diagnostics requires a well-trained and skilled workforce. The lack of skilled staff in developing countries is hampering growth of the global sepsis diagnostics market. However, lack of standard protocols has also become a challenge for the growth of market for the forecast period 2020-2025. 

Sepsis Diagnostics Industry outlook:
  • Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Sepsis Diagnostics Market. Key companies of this market are Abbott Laboratories, bioMerieux, Becton Dickinson Company, Danaher, Roche Diagnostics, T2 Biosystems, Luminex, Bruker, EKF Diagnostics, Thermo Fisher Scientific, Immunexpress, Response Biomedical, Axis-Shield Diagnostics, and CytoSorbents.

Acquisitions/Product Launches:
  • In July 2020, bioMerieux has announced the launch of Biofire Mycoplasma, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics.
  • In September 2019, Thermo Fisher Scientific signed an agreement with Lilly Oncology for companion diagnostic to be used with RET inhibitor.
1. Sepsis Diagnostics Market - Overview
    1.1 Definitions and Scope
2. Sepsis Diagnostics Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Technology
    2.3 Key trends by Product
    2.4 Key trends by Method
    2.5 Key trends by Pathogen
    2.6 Key trends by Test Type
    2.7 Key trends by End User
    2.8 Key trends by Geography
3. Sepsis Diagnostics Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies 
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Sepsis Diagnostics Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Sepsis Diagnostics Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Sepsis Diagnostics - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Sepsis Diagnostics Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Sepsis Diagnostics Market – By Technology (Market Size –$Million/$Billion)
    8.1 Blood Culture
    8.2 Immunoassays
    8.3 Molecular Diagnostics
        8.3.1 Polymerase Chain Reaction
        8.3.2 Microarrays
        8.3.3 Peptide nucleic acid fluorescent in situ hybridization
        8.3.4 Syndromic panel-based testing
    8.4 Flow Cytometry
    8.5 Microfluidics
    8.6 Biomarkers
9. Sepsis Diagnostics Market – By Product (Market Size – $Million/$Billion)
    9.1 Blood Culture Media
    9.2 Assays & Reagents
    9.3 Instruments
    9.4 Software
10. Sepsis Diagnostics Market – By Method (Market Size – $Million/$Billion)
    10.1 Conventional Diagnostics
    10.2 Automated Diagnostics
11. Sepsis Diagnostics Market – By Pathogen (Market Size – $Million/$Billion)
    11.1 Bacterial Sepsis
        11.1.1 Gram-negative bacterial sepsis
        11.1.2 Gram-positive bacterial sepsis
    11.2 Fungal Sepsis
    11.3 Other Pathogens
12. Sepsis Diagnostics Market – By Test Type (Market Size – $Million/$Billion)
    12.1 Laboratory Tests
    12.2 Point-Of-Care Tests
13. Sepsis Diagnostics Market – By End User (Market Size – $Million/$Billion)
    13.1 Hospitals
    13.2 Pathology & Reference Laboratories
    13.3 Research Laboratories & Academic Institutes
14. Sepsis Diagnostics Market - By Geography (Market Size – $Million/$Billion)
    14.1 North America
        14.1.1 U.S.
        14.1.2 Canada
        14.1.3 Mexico
    14.2 Europe
        14.2.1 U.K.
        14.2.2 Germany
        14.2.3 France
        14.2.4 Italy
        14.2.5 Spain
        14.2.6 Rest of Europe
    14.3 Asia-Pacific
        14.3.1 China
        14.3.2 India
        14.3.3 Japan
        14.3.4 South Korea
        14.3.5 Australia & New Zealand
        14.3.6 Rest of Asia-Pacific
    14.4 Rest of the World
        14.4.1 Middle East
        14.4.2 Africa
        14.4.3 South America
15. Sepsis Diagnostics Market - Entropy
16. Sepsis Diagnostics Market – Industry/Segment Competition Landscape Premium 
    16.1 Market Share Analysis
        16.1.1 Global Market Share – Key Companies
        16.1.2 Market Share by Region – Key companies
        16.1.3 Market Share by Countries – Key Companies
        16.1.4 Best Practices for Companies
17. Sepsis Diagnostics Market – Key Company List by Country Premium Premium
18. Sepsis Diagnostics Market Company Analysis
    18.1 Company 1
    18.2 Company 2
    18.3 Company 3
    18.4 Company 4
    18.5 Company 5
    18.6 Company 6
    18.7 Company 7
    18.8 Company 8
    18.9 Company 9
    18.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.